Hydrogen sulfide and endothelium-dependent vasorelaxation

Molecules

Volumn 19, Issue 12, 2014, Pages 21183-21199

  Bełtowski, Jerzy ^a   Jamroz Wis̈niewska, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cyclic gmp; Endothelium derived hyperpolarizing factor; Hydrogen sulfide; Nitric oxide; Nitroxyl; Perivascular sensory neurons; Potassium channels; Protein kinase g

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED RELAXING FACTOR; HYDROGEN SULFIDE; LEPTIN; NITRIC OXIDE;

ANIMAL; BLOOD VESSEL; DRUG EFFECTS; HUMAN; METABOLISM; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; BLOOD VESSELS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; HUMANS; HYDROGEN SULFIDE; LEPTIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; VASODILATION;

EID: 84919741132     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules191221183     Document Type: Review

References (69)

1. Abe, K.; Kimura, H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 1996, 16, 1066-1071.
2. 2 S be the third endogenous gaseous transmitter? FASEB J. 2002, 16, 1792-1798.
3. Wang, R. Gasotransmitters: Growing pains and joys. Trends Biochem. Sci. 2014, 39, 227-232, doi:10.1016/j.tibs.2014.03.003.
4. Kimura, H. Hydrogen sulfide and polysulfides as biological mediators. Molecules 2014, 19, 16146-16157.
5. Zhang, X.; Bian, J.S. Hydrogen sulfide: A neuromodulator and neuroprotectant in the central nervous system. ACS Chem. Neurosci. 2014, 5, 876-883, doi:10.1021/cn500185g.
6. Kashfi, K.; Olson, K.R. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Biochem Pharmacol. 2013, 85, 689-703, doi:10.1016/j.bcp.2012.10.019.
7. Popov, D. An outlook on vascular hydrogen sulphide effects, signalling, and therapeutic potential. Arch. Physiol. Biochem. 2013, 119, 189-194, doi:10.3109/13813455.2013.803578.
8. Hosoki, R.; Matsuki, N.; Kimura, H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 1997, 237, 527-531.
9. 2S as a novel endogenous gaseous KATP channel opener. EMBO J. 2001, 20, 6008-6016.
10. Polhemus, D.J.; Lefer, D.J. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ. Res. 2014, 114, 730-737.
11. Bełtowski, J.; Jamroz-Wis̈niewska, A.; Tokarzewska, D. Hydrogen sulfide and its modulation in arterial hypertension and atherosclerosis. Cardiovasc Hematol Agents Med. Chem. 2010, 8, 173-186.
12. Bełtowski, J. Endogenous hydrogen sulfide in perivascular adipose tissue: Role in the regulation of vascular tone in physiology and pathology. Can. J. Physiol. Pharmacol. 2013, 91, 889-898, doi:10.1139/cjpp-2013-0001.
13. Yu, X.H.; Cui, L.B.; Wu, K.; Zheng, X.L; Cayabyab, F.S.; Chen, Z.W.; Tang, C.K. Hydrogen sulfide as a potent cardiovascular protective agent. Clin. Chim. Acta 2014, 437, 78-87, doi:10.1016/j.cca.2014.07.012.
14. Meng, G.; Ma, Y.; Xie. L.; Ferro, A.; Ji, Y. Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. Br. J. Pharmacol. 2014, doi:10.1111/bph.12900.
15. Triggle, C.R.; Samuel, S.M.; Ravishankar, S.; Marei, I.; Arunachalam, G.; Ding, H. The endothelium: Influencing vascular smooth muscle in many ways. Can. J. Physiol. Pharmacol. 2012, 90, 713-738, doi:10.1139/y2012-073.
16. Michel, T.; Vanhoutte, P.M. Cellular signaling and NO production. Pflugers Arch. 2010, 459, 807-816, doi:10.1007/s00424-009-0765-9.
17. Heiss, E.H.; Dirsch, V.M. Regulation of eNOS enzyme activity by posttranslational modification. Curr. Pharm. Des. 2014, 20, 3503-3513.
18. Tang, E.H.; Vanhoutte, P.M. Endothelial dysfunction: A strategic target in the treatment of hypertension? Pflugers Arch. 2010, 459, 995-1004, doi:10.1007/s00424-010-0786-4.
19. Jin, X.; Satoh-Otonashi, Y.; Zamami, Y.; Takatori, S.; Hashikawa-Hobara, N.; Kitamura, Y.; Kawasaki, H. New molecular mechanisms for cardiovascular disease: contribution of endothelium-derived hyperpolarizing factor in the regulation of vasoconstriction in peripheral resistance arteries. J. Pharmacol. Sci. 2011, 116, 332-336.
20. Garland, C.J.; Hiley, C.R.; Dora, K.A. EDHF: Spreading the influence of the endothelium. Br. J. Pharmacol . 2011, 164, 839-852, doi:10.1111/j.1476-5381.2010.01148.x.
21. Félétou, M.; Vanhoutte, P.M. EDHF: An update. Clin. Sci. (Lond.) 2009, 117, 139-155, doi:10.1042/CS20090096.
22. + channels in normal and impaired EDHF-dilator responses-Relevance to cardiovascular pathologies and drug discovery. Br. J. Pharmacol. 2009, 157, 509-526, doi:10.1111/j.1476-5381.2009.00132.x.
23. a channels: An update on their pharmacology and usefulness as cardiovascular targets. J. Cardiovasc Pharmacol. 2013, 61, 102-112, doi:10.1097/FJC.0b013e318279ba20.
24. Kimura, H. Hydrogen sulfide: Its production, release and functions. Amino Acids 2011, 41, 113-121, doi:10.1007/s00726-010-0510-x.
25. 2S biogenesis by human cystathionine γ-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia. J. Biol. Chem. 2009, 284, 11601-11612, doi:10.1074/jbc.M808026200.
26. 2 S biogenesis via alternative trans-sulfuration reactions. J. Biol. Chem. 2009, 284, 22457-22466, doi:10.1074/jbc.M109.010868.
27. Jackson, M.R.; Melideo, S.L.; Jorns, M.S. Human sulfide: Quinone oxidoreductase catalyzes the first step in hydrogen sulfide metabolism and produces a sulfane sulfur metabolite. Biochemistry 2012, 51, 6804-6815.
28. Olson, K.R. Hydrogen sulfide as an oxygen sensor. Clin. Chem. Lab. Med. 2013, 51, 623-632, doi:10.1515/cclm-2012-0551.
29. 2S, hydropersulfides, and derived species: Implications of their possible biological activity and utility. Free Radic. Biol. Med. 2014, 77, 82-94, doi:10.1016/j.freeradbiomed.2014.09.007.
30. Toohey, J.I.; Cooper, A.J. Thiosulfoxide (sulfane) sulfur: New chemistry and new regulatory roles in biology. Molecules. 2014, 19, 12789-12813, doi:10.3390/molecules190812789.
31. 2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine γ-lyase. Science 2008, 322, 587-590, doi:10.1126/science.1162667.
32. 2+ concentrations. Biochem. Biophys. Res. Commun. 2013, 431, 131-135, doi:10.1016/j.bbrc.2013.01.010.
33. Shibuya, N.; Mikami, Y.; Kimura, Y.; Nagahara, N.; Kimura, H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J. Biochem. 2009, 146, 623-626, doi:10.1093/jb/mvp111.
34. Mustafa, A.K.; Sikka, G.; Gazi, S.K.; Steppan, J.; Jung, S.M.; Bhunia, A.K.; Barodka, V.M.; Gazi, F.K.; Barrow, RK.; Wang, R.; et al . Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res. 2011, 109, 1259-1268, doi:10.1161/CIRCRESAHA.111.240242.
35. Jamroz-Wis̈niewska, A.; Gertler, A.; Solomon, G.; Wood, M.E.; Whiteman, M.; Bełtowski, J. Leptin-induced endothelium-dependent vasorelaxation of peripheral arteries in lean and obese rats: Role of nitric oxide and hydrogen sulfide. PLoS One 2014, 9, e86744, doi:10.1371/journal.pone.0086744.
36. 2S is an endothelium-derived hyperpolarizing factor. Antioxid. Redox Signal. 2013, 19, 1634-1646, doi:10.1089/ars.2012.4805.
37. Baragatti, B.; Ciofini, E.; Sodini, D.; Luin, S.; Scebba, F.; Coceani, F. Hydrogen sulfide in the mouse ductus arteriosus: A naturally occurring relaxant with potential EDHF function. Am. J. Physiol. Heart Circ. Physiol. 2013, 304, H927-H934, doi:10.1152/ajpheart.00718.2012.
38. Han, J.; Chen, Z.W.; He, G.W. Acetylcholine- and sodium hydrosulfide-induced endothelium-dependent relaxation and hyperpolarization in cerebral vessels of global cerebral ischemia-reperfusion rat. J. Pharmacol. Sci. 2013, 121, 318-326.
39. Yoo, H.J.; Choi, K.M. Adipokines as a novel link between obesity and atherosclerosis. World J. Diabetes 2014, 5, 357-363, doi:10.4239/wjd.v5.i3.357.
40. Ohashi, K.; Shibata, R.; Murohara, T.; Ouchi, N. Role of anti-inflammatory adipokines in obesityrelated diseases. Trends Endocrinol. Metab. 2014, 25, 348-355, doi:10.1016/j.tem.2014.03.009.
41. Chai, S.B.; Sun, F.; Nie, X.L.; Wang, J. Leptin and coronary heart disease: A systematic review and meta-analysis. Atherosclerosis 2014, 233, 3-10, doi:10.1016/j.atherosclerosis.2013.11.069.
42. Toda, N.; Okamura, T. Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: An overview. J. Clin. Pharmacol. 2013, 53, 1228-1239, doi:10.1002/jcph.179.
43. Payne, G.A.; Tune, J.D.; Knudson, J.D. Leptin-induced endothelial dysfunction: A target for therapeutic interventions. Curr. Pharm. Des. 2014, 20, 603-608.
44. Bełtowski, J.; Wójcicka, G.; Jamroz-Wis̈niewska, A.; Wojtak, A. Chronic hyperleptinemia induces resistance to acute natriuretic and NO-mimetic effects of leptin. Peptides 2010, 31, 155-163, doi:10.1016/j.peptides.2009.10.012.
45. Bełtowski, J.; Wójcicka, G.; Jamroz-Wis̈niewska, A.; Marciniak, A. Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome. Life Sci. 2010, 85, 557-567, doi:10.1016/j.lfs.2009.08.002.
46. Haddock, R.E.; Grayson, T.H.; Morris, M.J.; Howitt, L.; Chadha, P.S.; Sandow, S.L. Diet-induced obesity impairs endothelium-derived hyperpolarization via altered potassium channel signaling mechanisms. PLoS One 2011, 6, e16423, doi:10.1371/journal.pone.0016423.
47. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am. J. Physiol. Heart Circ. Physiol. 2002, 283, H474-H480.
48. Geng, B.; Cui, Y.; Zhao, J.; Yu, F.; Zhu, Y.; Xu, G.; Zhang, Z.; Tang, C.; Du, J. Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats. Am. J. Physiol. Regul Integr. Comp. Physiol. 2007, 293, R1608-R1618.
49. Kubo, S.; Doe, I.; Kurokawa, Y.; Nishikawa, H.; Kawabata, A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: Contribution to dual modulation of vascular tension. Toxicology 2007, 232, 138-146.
50. Kubo, S.; Kurokawa, Y.; Doe, I.; Masuko, T.; Sekiguchi, F.; Kawabata, A. Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase. Toxicology 2007, 241, 92-97.
51. Predmore, B.L.; Julian, D.; Cardounel, A.J. Hydrogen sulfide increases nitric oxide production from endothelial cells by an akt-dependent mechanism. Front Physiol . 2011, 2, 104, doi:10.3389/fphys.2011.00104.
52. Kida, M.; Sugiyama, T.; Yoshimoto, T.; Ogawa, Y. Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells. Eur. J. Pharm. Sci. 2013, 48, 211-215, doi:10.1016/j.ejps.2012.11.001.
53. Coletta, C.; Papapetropoulos, A.; Erdelyi, K.; Olah, G.; Módis, K.; Panopoulos, P.; Asimakopoulou, A.; Gerö, D.; Sharina, I.; Martin, E.; et al . Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc. Natl. Acad. Sci. USA 2012, 109, 9161-9166, doi:10.1073/pnas.1202916109.
54. Altaany, Z.; Yang, G.; Wang, R. Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells. J. Cell. Mol. Med. 2013, 17, 879-888, doi:10.1111/jcmm.12077.
55. King, A.L.; Polhemus, D.J.; Bhushan, S.; Otsuka, H.; Kondo, K.; Nicholson, C.K.; Bradley, J.M.; Islam, K.N.; Calvert, J.W.; Tao, Y.X.; et al. Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent. Proc. Natl. Acad. Sci. USA 2014, 111, 3182-3187, doi:10.1073/pnas.1321871111.
56. Altaany, Z.; Ju, Y.; Yang, G.; Wang, R. The coordination of S-sulfhydration, S-nitrosylation, and phosphorylation of endothelial nitric oxide synthase by hydrogen sulfide. Sci. Signal. 2014, 7, ra87, doi:10.1126/scisignal.2005478.
57. Bucci, M.; Papapetropoulos, A.; Vellecco, V.; Zhou, Z.; Zaid, A.; Giannogonas, P.; Cantalupo, A.; Dhayade, S.; Karalis, K.P.; Wang, R.; et al. cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation. PLoS One 2012, 7, e53319, doi:10.1371/journal.pone.0053319.
58. Burgoyne, J.R.; Madhani, M.; Cuello, F.; Charles, R.L.; Brennan, J.P.; Schröder, E.; Browning, D.D.; Eaton, P. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007, 317, 1393-1397.
59. Neo, B.H.; Kandhi, S.; Ahmad, M.; Wolin, M.S. Redox regulation of guanylate cyclase and protein kinase G in vascular responses to hypoxia. Respir. Physiol. Neurobiol. 2010, 174, 259-264, doi:10.1016/j.resp.2010.08.024.
60. Stubbert, D.; Prysyazhna, O.; Rudyk, O.; Scotcher, J.; Burgoyne, J.R.; Eaton, P. Protein kinase G Iα oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide. Hypertension 2014, 64, 1344-1351, doi:10.1161/HYPERTENSIONAHA.114.04281.
61. Andrews, K.L.; Irvine, J.C.; Tare, M.; Apostolopoulos, J.; Favaloro, J.L.; Triggle, C.R.; Kemp-Harper, B.K. A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries. Br. J. Pharmacol. 2009, 157, 540-550, doi:10.1111/j.1476-5381.2009.00150.x.
62. Favaloro, J.L.; Kemp-Harper, B.K. Redox variants of NO (NO and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms. Am. J. Physiol. Heart Circ. Physiol. 2009, 296, H1274-H1280, doi:10.1152/ajpheart.00008.2009.
63. Fukuto, J.M.; Cisneros, C.J.; Kinkade, R.L. A comparison of the chemistry associated with the biological signaling and actions of nitroxyl (HNO) and nitric oxide (NO). J. Inorg. Biochem. 2013, 118, 201-208, doi:10.1016/j.jinorgbio.2012.08.027.
64. Fukuto, J.M.; Carrington, S.J. HNO signaling mechanisms. Antioxid Redox Signal. 2011, 14, 1649-1657, doi:10.1089/ars.2010.3855.
65. Yong, Q.C.; Hu, L.F.; Wang, S.; Huang, D.; Bian, J.S. Hydrogen sulfide interacts with nitric oxide in the heart: Possible involvement of nitroxyl. Cardiovasc. Res. 2010, 88, 482-491, doi:10.1093/cvr/cvq248.
66. 2S and NO interplay: hydrogen sulfide and nitroprusside react directly to give nitroxyl (HNO). A new pharmacological source of HNO. J. Med. Chem. 2013, 56, 1499-1508, doi:10.1021/jm3012036.
67. 2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway. Nat. Commun. 2014, 5, 4381, doi:10.1038/ncomms5381.
68. Pozsgai, G.; Hajna, Z.; Bagoly, T.; Boros, M.; Kemény, Á.; Materazzi, S.; Nassini, R.; Helyes, Z.; Szolcsányi, J.; Pintér, E. The role of transient receptor potential ankyrin 1 (TRPA1) receptor activation in hydrogen-sulphide-induced CGRP-release and vasodilation. Eur. J. Pharmacol. 2012, 689, 56-64, doi:10.1016/j.ejphar.2012.05.053.
69. White, B.J.; Smith, P.A.; Dunn, W.R. Hydrogen sulphide-mediated vasodilatation involves the release of neurotransmitters from sensory nerves in pressurized mesenteric small arteries isolated from rats. Br. J. Pharmacol . 2013, 168, 785-793, doi:10.1111/j.1476-5381.2012.02187.x.